Zai Lab treats first patient in China in PANOVA-3 trial of TTFields
Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase 3 clinical trial of tumor treating fields ... Read More
Alphamab Oncology enrols patients for KN026-203 phase 2 clinical trial
Alphamab Oncology said that it has completed enrolling patients in China for its KN026-203 phase 2 clinical trial of the combination of KN026 and KN046 ... Read More
Aligos Therapeutics stops development of CHB drug candidate ALG-010133
Aligos Therapeutics has stopped further development of ALG-010133, its STOPS drug candidate, in chronic hepatitis B (CHB) owing to futility. The California-based clinical stage biopharma ... Read More